122 related articles for article (PubMed ID: 10882691)
1. Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation.
Yanagihara K; Tomono K; Sawai T; Kuroki M; Kaneko Y; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Maesaki S; Kadota J; Tashiro T; Kohno S
J Antimicrob Chemother; 2000 Jul; 46(1):69-72. PubMed ID: 10882691
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of erythromycin inhalation in chronic respiratory infection caused by Pseudomonas aeruginosa].
Yanagihara K; Tomono K; Sawai T; Sasaki E; Kakeya H; Yamamoto Y; Ohno H; Ogawa K; Kadota J; Koga H; Kohno S; Hirakata Y; Tashiro T
Kansenshogaku Zasshi; 1997 Apr; 71(4):337-41. PubMed ID: 9164089
[TBL] [Abstract][Full Text] [Related]
3. Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.
Yanagihara K; Tomono K; Imamura Y; Kaneko Y; Kuroki M; Sawai T; Miyazaki Y; Hirakata Y; Mukae H; Kadota J; Kohno S
J Antimicrob Chemother; 2002 May; 49(5):867-70. PubMed ID: 12003986
[TBL] [Abstract][Full Text] [Related]
4. Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection.
Yanagihara K; Kuroki M; Higuchi N; Ohno H; Higashiyama Y; Miyazaki Y; Hirakata Y; Mukae H; Tomono K; Mizuta Y; Kadota J; Tsukamoto K; Kohno S
Chemotherapy; 2007; 53(1):10-3. PubMed ID: 17192707
[TBL] [Abstract][Full Text] [Related]
5. Effects of combined treatment with ambroxol and ciprofloxacin on catheter-associated Pseudomonas aeruginosa biofilms in a rat model.
Lu Q; Yu J; Bao L; Ran T; Zhong H
Chemotherapy; 2013; 59(1):51-6. PubMed ID: 23816803
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Pseudomonas aeruginosa biofilms with a combination of fluoroquinolones and fosfomycin in a rat urinary tract infection model.
Mikuniya T; Kato Y; Ida T; Maebashi K; Monden K; Kariyama R; Kumon H
J Infect Chemother; 2007 Oct; 13(5):285-90. PubMed ID: 17982715
[TBL] [Abstract][Full Text] [Related]
7. Bacterial biofilm in chronic airway infection.
Ohgaki N
Kansenshogaku Zasshi; 1994 Jan; 68(1):138-51. PubMed ID: 8138670
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa.
Ishida H; Ishida Y; Kurosaka Y; Otani T; Sato K; Kobayashi H
Antimicrob Agents Chemother; 1998 Jul; 42(7):1641-5. PubMed ID: 9660997
[TBL] [Abstract][Full Text] [Related]
9. Effect of erythromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.
Nagata T; Mukae H; Kadota J; Hayashi T; Fujii T; Kuroki M; Shirai R; Yanagihara K; Tomono K; Koji T; Kohno S
Antimicrob Agents Chemother; 2004 Jun; 48(6):2251-9. PubMed ID: 15155229
[TBL] [Abstract][Full Text] [Related]
10. Microbiological appraisal of levofloxacin activity against Pseudomonas aeruginosa biofilm in combination with different calcium chanel blockers in vitro.
Elkhatib WF; Haynes VL; Noreddin AM
J Chemother; 2009 Apr; 21(2):135-43. PubMed ID: 19423465
[TBL] [Abstract][Full Text] [Related]
11. A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin.
Yamamoto Y; Izumikawa K; Hosogaya N; Morinaga Y; Nakamura S; Imamura Y; Miyazaki T; Sakamoto N; Ishimatu Y; Kakeya H; Yanagihara K; Yasuoka A; Kohno S
Intern Med; 2012; 51(11):1383-6. PubMed ID: 22687847
[TBL] [Abstract][Full Text] [Related]
12. Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.
Loo CY; Lee WH; Lauretani G; Scalia S; Cipolla D; Traini D; Young P; Ong HX
Pharm Res; 2018 Feb; 35(3):50. PubMed ID: 29417313
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
Elkhatib W; Noreddin A
Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
[TBL] [Abstract][Full Text] [Related]
14. Levofloxacin in patients with severe respiratory tract infection.
Odagiri S
Drugs; 1995; 49 Suppl 2():426-7. PubMed ID: 8549387
[No Abstract] [Full Text] [Related]
15. [Inhibition of biofilm formation by clarithromycin (CAM) in an experimental model of complicated bladder infection--in vitro study using automated simulation of urinary antimicrobial concentration].
Sano M; Kumamoto Y; Nishimura M; Tsukamoto T; Hirose T; Ohya S
Kansenshogaku Zasshi; 1994 Nov; 68(11):1306-17. PubMed ID: 7829898
[TBL] [Abstract][Full Text] [Related]
16. The inhibition of Pseudomonas aeruginosa biofilm formation by micafungin and the enhancement of antimicrobial agent effectiveness in BALB/c mice.
Kissoyan KA; Bazzi W; Hadi U; Matar GM
Biofouling; 2016 Aug; 32(7):779-86. PubMed ID: 27347641
[TBL] [Abstract][Full Text] [Related]
17. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
Saini H; Chhibber S; Harjai K
Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
[TBL] [Abstract][Full Text] [Related]
18. Interaction between biofilms formed by Pseudomonas aeruginosa and clarithromycin.
Yasuda H; Ajiki Y; Koga T; Kawada H; Yokota T
Antimicrob Agents Chemother; 1993 Sep; 37(9):1749-55. PubMed ID: 8239580
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of aerosol MP-376, a levofloxacin inhalation solution, in models of mouse lung infection due to Pseudomonas aeruginosa.
Sabet M; Miller CE; Nolan TG; Senekeo-Effenberger K; Dudley MN; Griffith DC
Antimicrob Agents Chemother; 2009 Sep; 53(9):3923-8. PubMed ID: 19528273
[TBL] [Abstract][Full Text] [Related]
20. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2012 Nov; 11():CD009528. PubMed ID: 23152277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
